“This is the first pharmacologic therapy that can treat obstructive sleep apnea in this way,” says ... The new indication ...

Researchers, including experts from the University of Missouri School of Medicine, explored the use of senolytics—drugs ...

Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

“This is the first pharmacologic therapy that can treat obstructive ... type of sleep apnea known as obstructive sleep apnea, which is a physical condition in which the muscles of the throat ...

Sleep apnea, a condition that disrupts breathing during sleep, affects millions of people worldwide, especially adults over ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

The FDA said the popular weight-loss drug should be combined with a reduced-calorie diet and increased physical activity. Obstructive sleep apnea happens ... But standard therapy with breathing ...

Sleep apnea, a sleep disorder typically managed with a medical device that aids in breathing, now has its first FDA-approved drug therapy, an Eli Lilly medicine initially developed as a treatment ...

About 30 million people suffer from sleep apnea in the US, Troxel told Fox News Digital. The agency said that along with the drug, a reduced-calorie diet and increased physical activity should ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

The Food and Drug Administration announced late Friday that it has approved Zepbound to treat obstructive sleep apnea for those ... a reduced-calorie diet and physical activity, the FDA said.

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight ... calorie diet and increased physical activity, drugmaker Eli ...